Jonathan Parker

Regional Sales Manager for EBSCO Health, covering the South of England and Wales.

[Jonathan Parker @Jonathanebsco]

Excited to be exhibiting at #CochraneLondon, Cochrane’s annual conference, taking place 4th-6th September 2023. Find out more and register today to join us there: https://t.co/NnZeZZrDI3 Visit us a stand no 5, 3rd floor to learn more about DynaMed/DynaMedex.

[Claire Honeybourne @choneybourne]

@KnockDoug talking about embedding @DynaMedex at @KingsCollegeNHS

[Claire Honeybourne @choneybourne]

Great day at the @EBSCOUK London Workshop today. Thank you to all the delegates for their engagement and enthusiasm. Thank you to our guest speakers @pipdivall and @KnockDoug.

[Claire Honeybourne @choneybourne]

#RCN23 day 3 https://t.co/Uk9Z9G5tor is mobile friendly @EBSCOUK

[Claire Honeybourne @choneybourne]

#RCN23 day 3. Use Dynamic Health to support revalidation @EBSCO_Health

[EBSCO Clinical Decisions @EBSCO_CD]

September is childhood #obesity month. Here’s what physicians should know about obesity in children and adolescents from the editors at DynaMed: https://t.co/UDgw635UoV #pediatrics

[EBSCO Clinical Decisions @EBSCO_CD]

Find a new algorithm for evaluation and management of #anaphylaxis in DynaMed : https://t.co/NKoh7bgxqD #EmergencyMed #CritCare

[EBSCO Clinical Decisions @EBSCO_CD]

Calculate personalized recommendations for first-line medications for your patient with #Type2Diabetes with this new #DynaMedDecisions tool: https://t.co/zz8kRHiNjA #T2D #diabetes

[EBSCO Clinical Decisions @EBSCO_CD]

Suspect opsoclonus-myoclonus in an adult patient? Use the diagnostic algorithm found here: https://t.co/5WvUxxpoGQ #neurology #NeuroTwitter

[EBSCO Clinical Decisions @EBSCO_CD]

Considering endoscopic retrograde cholangiopancreatography (#ERCP) for your patient? Find indications, preparation, and technical considerations in DynaMed. https://t.co/CcwGQhSoB8 #Gastroenterology #cholangitis

[EBSCO Clinical Decisions @EBSCO_CD]

NEW DynaMed topic: Technical Considerations and Preparation for Ultrasound-guided Procedures. Find it here: https://t.co/P7EVoqBaYc #ultrasound #PrimaryCare #orthopedics

[EBSCO UK @EBSCOUK]

Original research from @AnnalsofIM finds flexible #sigmoidoscopy screening is associated with long-term reduction in colorectal cancer incidence and mortality. Learn more: https://t.co/Z03vifpgMJ #ColorectalCancer #CancerScreening

[EBSCO Clinical Decisions @EBSCO_CD]

It is interesting when a study uses an unconventional comparator population. Read about a study that compared persons at high risk for #endocarditis to patients with diabetes. Could this introduce confounding? https://t.co/8UEq7CdSef #EBMFocus #CriticalAppraisal

[EBSCO UK @EBSCOUK]

Find coronary artery calcium (CAC) scoring and clinical applications in DynaMed: https://t.co/HkfLO0nwAV #cardiology #CardioTwitter

[EBSCO Clinical Decisions @EBSCO_CD]

EBSCO Clinical Decisions’ DynaMed was ranked number one on this year’s 2022 Best in KLAS: Software & Services for Clinical Decision Support – Point of Care Clinical Reference category.

Learn more: https://t.co/4QeO0uAnZo #BestinKLAS #BestinKLASAwards #BIK2022 #BIK22

[EBSCO Clinical Decisions @EBSCO_CD]

Should you consider #diabetes risk when choosing antihypertensive medications for your patients? Read about a new meta-analysis evaluating the effect of ACEIs and ARBs on type 2 diabetes risk. https://t.co/fttUAydRAT #hypertension #T2D

[EBSCO UK @EBSCOUK]

EBSCO FOLIO Electronic Resource Management (ERM), a modern, time-saving platform. Register for this webinar to find out how easy it is to manage licences, agreements and costs through EBSCO’s ERM: https://t.co/U2YdIAYroS

[EBSCO Clinical Decisions @EBSCO_CD]

Can #Omicron evade immunity? Early data suggests partially, yes. Read more here: https://t.co/uTlLLjlUgc #COVID19 #variant #COVIDvaccine

[EBSCO Clinical Decisions @EBSCO_CD]

Top five questions about #Omicron answered in the latest blog article from the Infectious Disease Team at DynaMed. https://t.co/uTlLLjlUgc #COVID19 #variant

[EBSCO UK @EBSCOUK]

Getting better insights on usage is a must-have. How can you streamline your usage data to tell the right story? Download our free playbook to learn more and read the results of a recent #LibraryAnalytics survey. https://t.co/mjSlYfIeIK